NCT01244334CompletedPhase 4
A Randomized, Masked Multi-center Safety & Efficacy Study of the Effects of Preoperative & Postoperative Cataract Surgery Use of Difluprednate Ophthalmic Emulsion, 0.05% Compared to Prednisolone Acetate Ophthalmic Suspension 1% on Visual Acuity & Corneal Edema.
Edward J. Holland3 sites in 1 country52 target enrollmentStarted: March 2009Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 52
- Locations
- 3
- Primary Endpoint
- Assess change from Baseline on visual acuity, corneal edema, and retinal thickness at Day 1
Study Overview
Brief Summary
The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 21 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Healthy male or female 21 years of age or older
- •Scheduled to undergo standard cataract surgery with topical anesthesia in both eyes within 6-25 days between surgeries.
- •Willing and able to administer eye drops and record the times the drops were instilled
- •Understand and are willing to sign the Informed Consent form
- •Willing to complete the entire course of the study.
Exclusion Criteria
- •Use of an eye medication or drops within 48 hours of the scheduled cataract surgery, other than the study medication or procedural solution required for surgery.
- •Known sensitivity to any of the ingredients in the study medications or similar medications.
- •Scheduled for 2nd eye cataract surgery earlier than 6 days or longer than 25 days apart.
- •Corneal edema in either eye.
- •Need for regional or general anesthesia during surgery.
- •Complicated cataract surgery, including use of iris hooks or iris stretchers.
- •Sight better than 20/100 in only one eye.
- •A history of previous intraocular surgery in either eye.
- •A history of uveitis, iritis, or intraocular inflammation.
- •Macular pathology of the retina.
- •Presence of glaucoma.
- •Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease.
- •History of steroid-related intraocular pressure (IOP) rise in the study eye.
- •Lack of an intact corneal epithelium.
- •Pupils that do not dilate to more than 5 mm prior to surgery or you require mechanical stretching of your pupil.
- •Diabetes mellitus.
- •Required use of a systemic steroidal or non-steroidal anti-inflammatory during the study period.
- •Doctor has determined the presence of a condition (i.e., UNCONTROLLED systemic disease) or a situation that may put the subject at significant risk, confound the study results or may interfere significantly with your participation in the study.
- •Females, who are pregnant, nursing an infant or planning a pregnancy.
- •Currently involved in another investigational study or have participated in one within the 30 days prior to entering this study.
- •Unable or unwilling to give signed informed consent prior to participation in any study-related procedures.
Arms & Interventions
Difluprednate Ophthalmic Emulsion 0.05%
Active Comparator
Intervention: Difluprednate ophthalmic emulsion 0.05% (Drug)
Prednisolone acetate suspension 0.1%
Active Comparator
Intervention: Prednisolone acetate 1% (Drug)
Outcomes
Primary Outcomes
Assess change from Baseline on visual acuity, corneal edema, and retinal thickness at Day 1
Time Frame: Change from Baseline in visual acuity, corneal edema, and retinal thickness at Day 1
Secondary Outcomes
- Assess change from Baseline on visual acuity, corneal edema, and retinal thickness at Day 15(change from Baseline on visual acuity, corneal edema, and retinal thickness at Day 15)
Investigators
Edward J. Holland
Sponsor Investigator
Cincinnati Eye Institute Northern Kentucky
Study Sites (3)
Loading locations...
Similar Trials
Completed
Phase 2
Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal ProtectionRenal Artery StenosisNCT00234585University of Toledo Health Science Campus100
Completed
Not Applicable
Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular LensCorneal AstigmatismCataractNCT03949335Johnson & Johnson Surgical Vision, Inc.272
Completed
Not Applicable
Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye DiscomfortOcular DrynessNCT05777798SIFI SpA28
Completed
Phase 3
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar StenosisLow Back PainLeg PainLumbar Spinal StenosisSpondylolisthesisNCT00405691Impliant, Ltd.450
Completed
Phase 3
Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV MelanomaMelanomaNCT00324155Bristol-Myers Squibb681